Similarly, activation of PA adventitial fibroblasts (PAAfs) in response to injury and matrix stiffness also regulates vascular remodeling in PAH (86), with their derived factors such as the Fibroblast Growth Factor-23 (FGF-23) noted to influence patient outcomes to treatment responses (87). Here, FGF23 is linked to pulmonary arterial hypertension.